GLP-1药物推动美国肥胖率下降，伴随专利竞争

本文如何被排名

Signal score

0 / 100

Composite score across the factors below. Higher = stronger signal that this story matters right now.

Newsworthiness bucket

Research

文章讨论了由药物创新和专利政策驱动的公共卫生领域的重要趋势。[lever_c_demoted from significant: ic=1 ai=0.1]

Source corroboration

Single-source cluster

Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.

Topics

product, policy

Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.

AI-industry relevance

Low

Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.

Story freshness

1 days old

Coverage has settled into its steady-state source set.

完整方法见我们的编辑标准。